ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,844.00
      -0.93%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.17
      -0.45%
      Bitcoin
      64,222.01
      -3.30%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Connect Biopharma Holdings Inc (CNTB)

      7. Connect Biopharma Holdings Inc (CNTB) News

      CNTB

      Connect Biopharma (CNTB)

      Connect Biopharma Holdings Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CNTB
      DateTimeSourceHeadlineSymbolCompany
      02/27/20249:00PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
      02/13/20244:30PMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:CNTBConnect Biopharma Holdings Inc
      02/13/20244:27PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
      02/13/20244:18PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
      02/12/20244:50PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
      12/12/20236:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
      11/21/20236:13AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
      11/01/20233:57PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
      10/20/20234:44PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
      09/12/20234:47PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
      09/12/20236:13AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
      07/14/20235:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
      06/23/20234:32PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
      06/01/20234:25PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
      04/11/20234:59PMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CNTBConnect Biopharma Holdings Inc
      04/11/20234:05PMGlobeNewswire Inc.Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
      03/21/20234:53PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
      03/18/20232:40PMBusiness WireConnect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient SymptomsNASDAQ:CNTBConnect Biopharma Holdings Inc
      03/17/20234:05PMBusiness WireConnect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body RegionsNASDAQ:CNTBConnect Biopharma Holdings Inc
      03/06/20238:15AMBusiness WireConnect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual MeetingNASDAQ:CNTBConnect Biopharma Holdings Inc
      02/14/20236:33AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
      02/09/202310:02AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
      02/09/20236:07AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
      02/06/20238:30AMGlobeNewswire Inc.Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom CaliforniaNASDAQ:CNTBConnect Biopharma Holdings Inc
      02/03/20236:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
      01/03/20234:32PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNTBConnect Biopharma Holdings Inc
      12/30/20228:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
      12/30/20227:30AMGlobeNewswire Inc.Connect Biopharma Provides Business and Clinical Development Program UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
      12/19/20228:00AMGlobeNewswire Inc.Connect Biopharma to Present at the San Francisco Biotech Showcase in JanuaryNASDAQ:CNTBConnect Biopharma Holdings Inc
      12/02/20225:16PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
       Showing the most relevant articles for your search:NASDAQ:CNTB